Regeneron Pharmaceuticals (REGN)

$896.82 2.83 (0.32%)

16:00 EDT REGN Stock Quote Delayed 30 Minutes

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

7 Undervalued Biotech Stocks to Buy Before They Boom

Volume:

Previous Close -

Market Cap 82.31B

PE Ratio 25.80

EPS 34.76

Volume (Avg. Vol.) 501,399

Day's Range $891.46 - $920.73

52-Week Range $684.80 - $998.33

Dividend & Yield N/A (N/A)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

From InvestorPlace
From the Web

Our 7 Top Biotech Stock Picks for 2023

By Josh Enomoto, InvestorPlace Contributor Dec 9, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?

By William White, InvestorPlace Writer Nov 17, 2022

CytomX Therapeutics (CTMX) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (REGN).

7 Cash-Rich Stocks to Buy for Peace of Mind

By Will Ashworth, InvestorPlace Contributor Nov 4, 2022

It pays to hold cash-rich stocks that can weather any storm because of their financial strength. These seven stocks are such companies.

These 7 Biotech Stocks Are Set to Boom in 2023

By Chris Markoch, InvestorPlace Contributor Oct 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

The 3 Best Healthcare Stocks to Buy Now

By Larry Ramer, InvestorPlace Contributor Sep 9, 2022

Investors are less worried about the regulation of the U.S. healthcare sector, making this a good time to buy the best healthcare stocks.

5 Top Stocks Cathie Wood Is Selling This Week

By Eddie Pan, InvestorPlace Financial News Writer Aug 26, 2022

Cathie Wood's ARKK received $54.2 million of inflows earlier this month, the most in a five-day period since May. Here's what she's selling.

7 Cathie Wood Stocks to Buy on the Dip

By Alex Sirois, InvestorPlace Contributor Aug 22, 2022

Cathie Wood stocks lost some of their shine in the tech wreck. But the second half of 2022 looks much brighter for these picks.

3 Biotech Stocks Outperforming a Bear Market

By Jaimini Desai Jul 15, 2022

These biotech stocks are the most attractive from a valuation and growth perspective as they are less impacted by a slowing economy or change in monetary policy.

7 Safe Stocks to Buy to Guard Against a Recession

By Louis Navellier and the InvestorPlace Research Staff Apr 5, 2022

It's not too late to buy safe stocks. These seven stocks, all A-rated, are perfect plays for riding out continued volatility in the markets.

Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead

By William White, InvestorPlace Writer Mar 10, 2022

We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.

7 Low Volatility Stocks to Buy Right Now for Steady Returns

By Brian Paradza, CFA Feb 24, 2022

A great way to find low volatility stocks is to look for a beta that's less than 1.0. Here are seven to buy as market turbulence increases.

3 Biotech Stocks That Could Boom or Bust in Q1

By Joel Baglole, InvestorPlace Contributor Feb 1, 2022

The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future.

Regeneron: Surfing on Covid, With More Under the Surface

By Dana Blankenhorn, InvestorPlace Contributor Dec 2, 2021

Regeneron has made billions from its Covid-19 drug, and it has new drugs like Dupixent that could make many billions more.

7 Biotech Stocks Entering the Golden Boom Phase

By Chris Lau, InvestorPlace Contributor Sep 28, 2021

These biotech stocks offer a more mature take on an otherwise risky sector. These companies already have successes under their belt.

7 Gene Editing Stocks Promising to Change our DNA

By Chris Markoch, InvestorPlace Contributor Sep 15, 2021

Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market.

4 Top Stock Trades for Friday: SQ, REGN, WBA, CRWD

By Bret Kenwell, InvestorPlace Contributor Jul 1, 2021

Square, Regeneron, Walgreen and CrowdStrike were our top stock trades for Friday. Let's get a look at how the charts are setting up now.

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor Apr 26, 2021

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

Vaccine Passport Potential Could Boost These 7 Pharmaceutical Stocks

By Chris Lau, InvestorPlace Contributor Apr 12, 2021

Nearly everyone will get the Covid-19 vaccination, suggesting strong revenue for a handful of pharmaceutical companies.

7 Best Stocks on the Nasdaq

By Chris Lau, InvestorPlace Contributor Apr 6, 2021

Investors need to hold the best companies that money can buy on the Nasdaq, amid a growing weakness in the technology stock index.

7 Stocks That Cathie Wood Likes and You Should Too

By Josh Enomoto, InvestorPlace Contributor Mar 11, 2021

The anti-Wolf of Wall Street, Cathie Wood brings honesty and integrity to the world of high finance. Her strong track record confirms that nice folks can finish first.

Regeneron Pharmaceuticals (REGN)

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

7 Undervalued Biotech Stocks to Buy Before They Boom

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Regeneron Pharmaceuticals (REGN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

Subscriber Sign in